Mitchell Capital Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Mitchell Capital Management’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-7,934	Closed	-$428K	–	120
2017 Q4	$428K	Sell	7,934 -978	-11%	-$53.5K	0.15%	58
2017 Q3	$509K	Sell	8,912 -229	-3%	-$13.4K	0.19%	50
2017 Q2	$550K	Sell	9,141 -124	-1%	-$7.06K	0.21%	47
2017 Q1	$505K	Buy	+9,265	New	+$456K	0.19%	51

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Mitchell Capital Management's BIVV Position: Q1 2018 in Review

Mitchell Capital Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 7,934 shares — an estimated $428K sold.

Mitchell Capital Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $550K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Mitchell Capital Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Mitchell Capital Management sold 7,934 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $428K.
Mitchell Capital Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Mitchell Capital Management's Bioverativ Inc. Common Stock position peaked at $550K in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Mitchell Capital Management's 13F filing for Q1 2018, filed 4 May 2018.